Sandoz has more than 25 years of experience when it comes to recombinant products. In 1980, we were one of the first companies to introduce industrial scale fermentation of Interferon Alpha, one of the first recombinant proteins.

Access to leading development technologies and large scale production capacities is our key differentiator, giving our customers the flexibility they need in the development and production of recombinant products. Sandoz offers state-of-the-art production facilities for recombinant human and animal proteins as well as industrial enzymes. One of our core strengths is the microbial fermentation of recombinant organisms such as E.coli and various yeasts. In this field, we offer fermentation at scales of 1 300 L, 3 000 L, 13 000 L and 40 000 L.

Download our Recombinant Microbial brochure

Pioneering Biosimilars

Sandoz is the pioneer and undisputed global leader in the rapidly emerging market for biosimilars. Visit our stand-alone Biosimilars website to find out more


Frequently Asked Questions

Everything you wanted to know about the generics industry. More